【摘要】急性肾损伤是血管内应用对比剂后最常见不良反应之一，尤其在肾病患者中风险增加。如何降低其风险一直是临床关注的重点。2020 年1 月美国放射学会与美国肾脏病基金会联合发布肾病患者碘对比剂应用共识，从定义、诊断标准、危险因素、合并用药、预防措施、特殊人群等方面进行更新阐述。本文结合国内外其他相关指南及文献，对其进行解读。
【Abstract】Acute kidney injury is one of the most common adverse reaction after intravascular administration of contrast media, especially with increased risk in kidney disease patients. How to reduce the risk has always been an important issue in clinical practice. In January 2020, the American College of Radiology and the National Kidney Foundation issued consensus statements about use of iodinated contrast media in patients with kidney disease. These statements update the definition, diagnostic criteria, risk factors, combined use of drugs, preventive measures, special population and other aspects. This paper interprets these statements in association with other guidelines and relevant literature.
[1]Davenport MS, Perazella MA, Yee J, et al.Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease:Consensus Statements from the American College of Radiology and the National Kidney Foundation[J].Radiology, 2020, 00(0):1-9
[2]Van der Molen, Reimer P, Dekkers IA, et al.Post-contrast acute kidney injury-Part 1:Definition,clinical features,incidence,role of contrast medium and risk factors[J].European Radiology, 2018, 28(7):2845-2855
[3]中华医学会放射学分会对比剂安全使用工作组.碘对比剂使用指南第版[J].中华医学杂志, 2014, 94(43):3363-3369
[4]Pandya B, Chalhoub JM, Parikh V, et al.Contrast media use in patients with chronic kidney disease undergoing coronary angiography:A systematic review and meta-analysis of randomized trials[J].Int J Cardiol, 2017, 228(/):137-144
[5]Zhao F, Lei R, Yang SK, et al.Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients:a systematic review and meta-analysis[J].Cancer Imaging, 2019, 19(1):1-8
[6]施优波, 孙玲麟, 李强, 等.慢性肾病患者低辐射低碘量冠状动脉成像可行性分析[J].中华放射医学与防护杂志, 2020, 40(5):402-407
[7]宋魏, 吕梁, 刘兴利, 等.基于肝脏体积测量计算腹部增强扫描碘对比剂剂量个体化方案的可行性[J].中华放射学杂志, 2020, 54(05):403-407
[8]Wu YH, Wu CY, Cheng CY, et al.Sever hyperbilirubinemia is associated with higher risk of contrast-related acute kidney injury following contrast-enhanced computed tomography[J].PLOS ONE, 2020, 15(4):e0231264-e0231264
[9]Wang WD, Qu W, Sun D, et al.Meta-analysis of effect of renin-angiotensin-aldosterone system blockers on contrast-induced nephropathy[J].J Renin Angiotensin Aldosterone Syst, 2020, 21(2):1-8
[10]Jo SH, Lee JM, Park J, et al.The impact of renin-angiotensin-aldosterone system blockade on contrast-induced nephropathy:a meta-analysis of 12 studies with 4493 patients[J].Cardiology, 2015, 130(1):4-14
[11]Guo XS, Wu DX, Bei WJ, et al.Intensity of hydration changes the role of renin-angiotensin-aldosterone system blockers in contrast-induced nephropathy risk after coronary catheterisation in patients with chronic kidney disease[J].J Renin Angiotensin Aldosterone Syst, 2017, 18(2):1-8
[12]Kwon S, Kim YC, Park JY, et al.The Long-term Effects of Metformin on Patients With Type2 Diabetic Kidney Disease[J].Diabetes Care, 2020, 43(5):948-955
[13]中国医师协会内分泌代谢科医师分会.型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识年更新版[J].中华内分泌代谢杂志, 2019, 35(6):447-454
[14]Lalau JD, Kajbaf F, Bennis Y, et al.Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A,3B,or 4[J].Diabetes Care, 2018, 41(3):547-553
[15]Weisbord SD, Gallagher M, Jneid H, et al.Outcomes after angiography with sodium bicarbonate and acetylcysteine[J].N Engl J Med, 2018, 378(7):603-614
[16]Rezaei Y, Khademvatani K, Rahimi B, et al.Short-term high-dose vitamin E to prevent contrast medium-induced acute kidney injury in patients with chronic kidney disease undergoing elective coronary angiography:a randomized placebo-controlled trial[J].J Am Heart Assoc, 2016, 5(3):e002919-e002919
[17]Xu YX, Zheng XM, Liang BR, et al.Vitamins for prevention of contrast-induced acute kidney injury:A systematic review and trial sequential analysis[J].Am J Cardiovasc Drugs, 2018, 18(4):373-386
